Organisation profile

Organisation profile

Our mission is to improve patient care through the development of:

- Biomarkers for prognosis, prediction and markers of response;
- Biologically determined targeted therapies.


The Centre for Cancer Research & Cell Biology (CCRCB) at Queen's University Belfast is a cross-Faculty, interdisciplinary research centre with over 300 clinical and basic researchers from across the world and is committed to the highest quality of research excellence. To achieve our mission we are pursuing the highest quality clinical and basic science research programmes. The hallmark of our research programme is a close, collaborative interaction between clinical and laboratory research experts that ultimately enhances the quality and scope of our integrated basic and clinical research programmes in cancer as well as other diseases.

Fingerprint Dive into the research topics where Centre for Cancer Research and Cell Biology is active. These topic labels come from the works of this organisation's members. Together they form a unique fingerprint.

  • Network Recent external collaboration on country level. Dive into details by clicking on the dots.

    Research Output

    125 years of BJR and radiological research: a celebration of the world's oldest radiology journal

    Jackson, S. A. & Prise, K. M., 01 Jan 2020, In : British Journal of Radiology. 93, 1105, 20209001.

    Research output: Contribution to journalEditorial

    Open Access
    File
    16 Downloads (Pure)

    Alcohol intake, tobacco smoking, and esophageal adenocarcinoma survival: a molecular pathology epidemiology cohort study

    McCain, R. S., McManus, D. T., McQuaid, S., James, J. A., Salto-Tellez, M., Reid, N. B., Craig, S., Chisambo, C., Bingham, V., McCarron, E., Parkes, E., Turkington, R. C. & Coleman, H. G., 01 Jan 2020, In : Cancer Causes and Control. 31, 1, p. 1-11

    Research output: Contribution to journalArticle

    Open Access
    File
  • 26 Downloads (Pure)

    A novel next generation sequencing approach to improve sarcoma diagnosis

    McConnell, L., Houghton, O., Stewart, P., Gazdova, J., Srivastava, S., Kim, C., Catherwood, M., Strobl, A., Flanagan, A. M., Oniscu, A., Kroeze, L. I., Groenen, P., Taniere, P., Salto-Tellez, M. & Gonzalez, D., 11 Feb 2020, In : Modern Pathology .

    Research output: Contribution to journalArticle

  • Prizes

    2007 The Liebig Lectureship of the German Chemical Society (GDCh)

    Karl Hale (Recipient), 2007

    Prize: Prize (including medals and awards)

  • 2010 Japan Society for the Promotion of Science Invitation Research Fellowship

    Karl Hale (Recipient), 2010

    Prize: Prize (including medals and awards)

  • Activities

    NEMHESYS

    Ken Mills (International committee member)
    03 Mar 2020

    Activity: Participating in or organising an event typesParticipation in workshop, seminar, course

    Royal College of Pathologists NI Symposium

    Ken Mills (Chair)
    22 Apr 2020

    Activity: Participating in or organising an event typesParticipation in conference

    NCRI Working Group on MDS (External organisation)

    Ken Mills (Advisor)
    28 Feb 2020

    Activity: Membership typesMembership of network

    Impact

    Development and Commercialization of a Technology Platform to Enable Biomarker Discovery and Validation

    Richard Kennedy (Participant), Paul Harkin (Participant), Patrick Johnston (Participant), Alison Hosey (Participant), Julia Miskelly (Participant), Margaret Murray (Participant), Jennifer Quinn (Participant), Colin James (Participant), Jude Mulligan (Participant), Peter Daly (Participant), Paul Mullan (Participant), Julie Mussen (Participant), Ultan McDermott (Participant), Richard Wilson (Participant), Daniel Longley (Participant)

    Impact: Health Impact, Quality of Life Impact

    Identifying Patients with Rare Forms of Erythrocytosis

    Mary Frances McMullin (Participant), Terence Lappin (Participant), Anne Hughes (Participant)

    Impact: Health Impact, Quality of Life Impact

    Successful Commercial Exploitation of Digital Pathology for Cancer Education, Biomarker Discovery and Clinical Diagnosis

    Peter Hamilton (Participant), James Diamond (Participant), Yinhai Wang (Participant), Ching-Wei Wang (Participant), Paul Kelly (Participant), Jacqueline James (Participant), Dean Fennell (Participant)

    Impact: Health Impact, Quality of Life Impact